REZZAYO

REZAFUNGIN · Melinta Therapeutics, LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for REZZAYO, covering 2023-03-22 to 2026-06-15. Get the full timeline:

Most recent: EMA Authorised: Rezzayo (rezafungin) — Mundipharma GmbH